• AGC Biologics and Horizon Therapeutics plc Expand Partnership prnasia
    October 30, 2020
    AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced that its partnership with Horizon Therapeutics plc is expanding to produce Horizon's Thyroid Eye Disease (TED) treatment ...
PharmaSources Customer Service